European Medicines Agency: Received AKANTIOR ® Trade Name approval; Conducted favourable pre-Marketing Authorisation Applications meetings with designated Rapporteurs; Reiterated original guidance to ...
The CHMP recommendation will now be reviewed by the European Commission (EC), which may decide on the marketing authorisation (MA) for AKANTIOR ® in August 2024. The decision will then be applicable ...
Polihexanide 0.08% Exhibits Compelling Safety and Tolerability Characteristics in Healthy Volunteers CATANIA, Italy, Feb. 1, 2021 /PRNewswire/ -- SIFI, a leading ophthalmic company, announced today ...
CATANIA, Italy, Nov. 19, 2020 /PRNewswire/ -- SIFI, a leading ophthalmic company, announced today that it has achieved the full enrollment of 135 patients with Acanthamoeba keratitis (AK) in its ...
CATANIA, Italy, Sept. 30, 2024 /PRNewswire/ -- SIFI, a leading international ophthalmic company, announced that is has received a Notice of Allowance from the European Patent Office ("EPO") for ...
ACI SANT'ANTONIO, Italy, May 31, 2024 /PRNewswire/ -- SIFI announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ...
The study topline results expected in the second half of 2021 CATANIA, Italy, Nov. 19, 2020 /PRNewswire/ -- SIFI, a leading ophthalmic company, announced today that it has achieved the full enrollment ...
ACI SANT'ANTONIO, Italy, May 31, 2024 /PRNewswire/ -- SIFI announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results